Enanta Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2010
Revenue	79.2	86.16	97.07	122.47	205.2	206.63	102.81	88.27	160.88	47.74	Upgrade
Revenue Growth (YoY)	-8.07%	-11.24%	-20.74%	-40.31%	-0.69%	100.97%	16.48%	-45.13%	236.98%	48.94%	Upgrade
Gross Profit	79.2	86.16	97.07	122.47	205.2	206.63	102.81	88.27	160.88	47.74	Upgrade
Selling, General & Admin	52.89	45.48	32.54	27.36	26.25	23.44	20.75	16.97	13.54	10.02	Upgrade
Research & Development	163.52	164.52	174.11	136.76	142.21	94.86	57.45	40.46	23.19	18.74	Upgrade
Operating Expenses	216.41	210	206.65	164.11	168.46	118.3	78.2	57.43	36.73	28.76	Upgrade
Operating Income	-137.21	-123.84	-109.57	-41.64	36.74	88.33	24.61	30.84	124.15	18.99	Upgrade
Interest Expense / Income	5.15	0	0	0	0	0	-2.49	-1.69	0.01	0.02	Upgrade
Other Expense / Income	-11.36	-1.66	-1.99	-6.62	-8.82	-4.79	0.16	-0.03	-1.32	-0.3	Upgrade
Pretax Income	-131	-122.19	-107.58	-35.02	45.56	93.12	26.95	32.56	125.46	19.27	Upgrade
Income Tax	2.82	-0.43	-28.58	1.15	-0.83	21.17	9.24	10.89	46.46	-15.17	Upgrade
Net Income	-133.82	-121.76	-79	-36.17	46.38	71.96	17.71	21.67	78.99	34.44	Upgrade
Net Income Growth	-	-	-	-	-35.54%	306.30%	-18.26%	-72.57%	129.37%	-	Upgrade
Shares Outstanding (Basic)	21	21	20	20	20	19	19	19	19	18	Upgrade
Shares Outstanding (Diluted)	21	21	20	20	21	21	19	19	19	19	Upgrade
Shares Change	1.78%	2.14%	1.16%	-4.90%	1.54%	6.40%	0.95%	-0.37%	0.57%	96.00%	Upgrade
EPS (Basic)	-6.38	-5.91	-3.92	-1.81	2.37	3.74	0.93	1.14	4.23	1.88	Upgrade
EPS (Diluted)	-6.38	-5.91	-3.92	-1.81	2.21	3.48	0.91	1.13	4.09	1.80	Upgrade
EPS Growth	-	-	-	-	-36.49%	282.42%	-19.47%	-72.37%	127.22%	-	Upgrade
Free Cash Flow	-112.21	-86.91	-70.75	5.64	66	26.24	50.15	31.07	74.34	19.15	Upgrade
Free Cash Flow Per Share	-5.35	-4.22	-3.51	0.28	3.37	1.36	2.63	1.64	3.98	1.04	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-173.23%	-143.74%	-112.88%	-34.00%	17.90%	42.75%	23.94%	34.94%	77.17%	39.77%	Upgrade
Profit Margin	-168.95%	-141.31%	-81.38%	-29.53%	22.60%	34.82%	17.23%	24.55%	49.10%	72.14%	Upgrade
Free Cash Flow Margin	-141.67%	-100.87%	-72.88%	4.61%	32.16%	12.70%	48.77%	35.20%	46.21%	40.11%	Upgrade
Effective Tax Rate	-	-	-	-	-1.81%	22.73%	34.28%	33.46%	37.04%	-78.73%	Upgrade
EBITDA	-123.48	-119.22	-104.25	-31.38	48.82	95.64	26.59	32.53	126.1	19.64	Upgrade
EBITDA Margin	-155.90%	-138.36%	-107.39%	-25.62%	23.79%	46.29%	25.86%	36.85%	78.38%	41.13%	Upgrade
Depreciation & Amortization	2.37	2.97	3.33	3.64	3.26	2.52	2.14	1.66	0.64	0.35	Upgrade
EBIT	-125.85	-122.19	-107.58	-35.02	45.56	93.12	24.46	30.87	125.46	19.29	Upgrade
EBIT Margin	-158.89%	-141.82%	-110.82%	-28.59%	22.20%	45.07%	23.79%	34.97%	77.99%	40.40%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).